BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

R-Tech Ueno: Announcement of Commercial Availability of RESCULA® Eye Drops in the U.S. Market


2/21/2013 9:09:39 AM

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573): Sucampo Pharmaceuticals, Inc. (hereinafter referred to as "Sucampo") announced that RESCULA® Eye Drops had been launched in the U.S. market. (See Sucampo's press release dated February 19, 2013.) RESCULA® Eye Drops may be used as a first-line agent or concomitantly with other topical ophthalmic drug products with ocular hypotensive effect for treatment of open-angle glaucoma, which is the most common form of glaucoma, or ocular hypertension. RESCULA® Eye Drops is a BK channel activator, which is different from other intraocular pressure-lowering agents. Contract for assignment of marketing approval and dealership of RESCULA® Eye Drops, licensing of related patents, and exclusive manufacturing and provision of the product in the U.S. and Canada for indications of glaucoma and ocular hypertension was made between Sucampo and us in April 2009.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES